Cargando…

Bufei Huoxue Capsule Attenuates PM2.5-Induced Pulmonary Inflammation in Mice

Atmospheric fine particulate matter 2.5 (PM 2.5) may carry many toxic substances on its surface and this may pose a public health threat. Epidemiological research indicates that cumulative ambient PM2.5 is correlated to morbidity and mortality due to pulmonary and cardiovascular diseases and cancer....

Descripción completa

Detalles Bibliográficos
Autores principales:	Jing, Yue, Zhang, Hongchun, Cai, Zhe, Zhao, Yukun, Wu, Ye, Zheng, Xuan, Liu, Ying, Qin, Yuying, Gu, Mingjie, Jin, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350288/ https://www.ncbi.nlm.nih.gov/pubmed/28337225 http://dx.doi.org/10.1155/2017/1575793

Ejemplares similares

Systematic Pharmacology-Based Strategy to Explore the Mechanism of Bufei Huoxue Capsule in the Treatment of Chronic Obstructive Pulmonary Disease
por: Shi, Liangtian, et al.
Publicado: (2022)

Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial
por: Chen, Yuqin, et al.
Publicado: (2021)

Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial
por: Chen, Yuqin, et al.
Publicado: (2022)

Bufei Decoction Alleviated Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Mice by Anti-Inflammation
por: Yang, Shanjun, et al.
Publicado: (2020)

Zhilong Huoxue Tongyu capsule attenuates intracerebral hemorrhage induced redox imbalance by modulation of Nrf2 signaling pathway
por: Mazhar, Maryam, et al.
Publicado: (2023)

Gene Network Mechanism of Zhilong Huoxue Tongyu Capsule in Treating Cerebral Ischemia–Reperfusion
por: Li, Na, et al.
Publicado: (2022)

Effects and Mechanism of Bufei Yishen Formula in a Rat Chronic Obstructive Pulmonary Disease Model
por: Li, Jiansheng, et al.
Publicado: (2014)

Pharmacological effects of Bufei Jianpi granule on chronic obstructive pulmonary disease and its metabolism in rats
por: Yang, Xin-Xin, et al.
Publicado: (2022)

Sequential Treatments with Tongsai and Bufei Yishen Granules Reduce Inflammation and Improve Pulmonary Function in Acute Exacerbation-Risk Window of Chronic Obstructive Pulmonary Disease in Rats
por: Lu, Xiaofan, et al.
Publicado: (2016)

Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Investigation on the mechanisms of guiqi huoxue capsule for treating cervical spondylosis based on network pharmacology and molecular docking
por: Liu, Yingying, et al.
Publicado: (2021)

Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease
por: Dong, Yuqiong, et al.
Publicado: (2015)

Bufei Yishen granule combined with acupoint sticking improves pulmonary function and morphormetry in chronic obstructive pulmonary disease rats
por: Tian, Yange, et al.
Publicado: (2015)

Effects of Bufei Yishen Granules Combined with Acupoint Sticking Therapy on Pulmonary Surfactant Proteins in Chronic Obstructive Pulmonary Disease Rats
por: Tian, Yange, et al.
Publicado: (2016)

Bufei Yishen Granules Combined with Acupoint Sticking Therapy Suppress Inflammation in Chronic Obstructive Pulmonary Disease Rats: Via JNK/p38 Signaling Pathway
por: Tian, Yange, et al.
Publicado: (2017)

Herbal Formula, PM014, Attenuates Lung Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease
por: Lee, Hyojung, et al.
Publicado: (2012)

Exploring the Ferroptosis Mechanism of Zhilong Huoxue Tongyu Capsule for the Treatment of Intracerebral Hemorrhage Based on Network Pharmacology and In Vivo Validation
por: Wang, Lixia, et al.
Publicado: (2022)

Effects of transboundary PM(2.5) transported from China on the regional PM(2.5) concentrations in South Korea: A spatial panel-data analysis
por: Jun, Myung-Jin, et al.
Publicado: (2023)

Ophiopogonin D attenuates PM2.5-induced inflammation via suppressing the AMPK/NF-κB pathway in mouse pulmonary epithelial cells
por: Wang, Ying, et al.
Publicado: (2020)

Huoxue Qingre decoction used for treatment of coronary heart disease network analysis and metabolomic evaluation
por: Tan, Yu-Qing, et al.
Publicado: (2022)

Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease
por: Li, Jiansheng, et al.
Publicado: (2015)

Bufei Jianpi Granules Reduce Quadriceps Muscular Cell Apoptosis by Improving Mitochondrial Function in Rats with Chronic Obstructive Pulmonary Disease
por: Mao, Jing, et al.
Publicado: (2019)

Powdered Green Tea (Matcha) Attenuates the Cognitive Dysfunction via the Regulation of Systemic Inflammation in Chronic PM(2.5)-Exposed BALB/c Mice
por: Kim, Jong Min, et al.
Publicado: (2021)

Indoor PM(2.5) from occupied residences in Sweden caused higher inflammation in mice compared to outdoor PM(2.5)
por: Wierzbicka, Aneta, et al.
Publicado: (2022)

Zhilong Huoxue Tongyu capsule inhibits rabbit model of hyperlipidemia and atherosclerosis through NF-κB/NLRP3 signaling pathway
por: Liu, Mengnan, et al.
Publicado: (2023)

Ecklonia cava Attenuates PM(2.5)-Induced Cognitive Decline through Mitochondrial Activation and Anti-Inflammatory Effect
por: Park, Seon Kyeong, et al.
Publicado: (2021)

PM2.5‐induced pulmonary inflammation via activating of the NLRP3/caspase‐1 signaling pathway
por: Jia, Hui, et al.
Publicado: (2020)

circ_0038467 promotes PM2.5-induced bronchial epithelial cell dysfunction
por: Jin, Xuan, et al.
Publicado: (2021)

Metabolomics unveils the mechanism of Bufei Huayu decoction in combination with cisplatin against non-small cell lung cancer (NSCLC)
por: Feng, Yuan, et al.
Publicado: (2023)

Cirsilineol Treatment Attenuates PM(2.5)-Induced Lung Injury in Mice
por: Kim, Chaeyeong, et al.
Publicado: (2022)

Toxicity beyond the Lung: Connecting PM(2.5), Inflammation, and Diabetes
por: Potera, Carol
Publicado: (2014)

Yiqi Huoxue preserves heart function by upregulating the Sigma-1 receptor in rats with myocardial infarction
por: Lou, Lixia, et al.
Publicado: (2021)

The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats
por: Mao, Jing, et al.
Publicado: (2022)

Zhilong Huoxue Tongyu Capsules' Effects on ischemic stroke: An assessment using fecal 16S rRNA gene sequencing and untargeted serum metabolomics
por: Wang, Raoqiong, et al.
Publicado: (2022)

Bufei Decoction Improves Lung-Qi Deficiency Syndrome of Chronic Obstructive Pulmonary Disease in Rats by Regulating the Balance of Th17/Treg Cells
por: Shen, Junxi, et al.
Publicado: (2022)

The airway inflammation induced by nasal inoculation of PM2.5 and the treatment of bacterial lysates in rats
por: Shen, Yang, et al.
Publicado: (2018)

Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression
por: Wang, Weimin, et al.
Publicado: (2023)

The Influence of BuqiHuoxueTongluo Formula on Histopathology and Pulmonary Function Test in Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats
por: Yu, Xiaolin, et al.
Publicado: (2018)

Effect of Bufei Yishen Granules Combined with Electroacupuncture in Rats with Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-κB Signaling
por: Ma, Jindi, et al.
Publicado: (2019)

Effect of Traditional Chinese Medicine Bufei Granule on Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis Based on Existing Evidence
por: Fan, Yihua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4tgqbo0ldvq1kgspjem01d8vsm